Mitochondria in the elderly: Is acetylcarnitine a rejuvenator?

Advanced Drug Delivery Reviews

Volumn 61, Issue 14, 2009, Pages 1332-1342

  Rosca, Mariana G ^a   Lemieux, Hélène ^a   Hoppel, Charles L ^a  

^a CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Acetyl CoA; Aging; Complex III; Electron transport chain complexes; Mitochondrial biogenesis; Mitochondrial metabolism; Mitochondrial proteins

Indexed keywords

ACETYL-COA; ELECTRON TRANSPORT CHAIN; MITOCHONDRIAL BIOGENESIS; MITOCHONDRIAL METABOLISM; MITOCHONDRIAL PROTEIN;

AMINES; AMINO ACIDS; ANIMALS; BIOCHEMISTRY; CARBOHYDRATES; ELECTRON TRANSITIONS; ELECTRON TRANSPORT PROPERTIES; FATTY ACIDS; GENE EXPRESSION; KETONES; METABOLISM; ORGANIC ACIDS; PHOSPHORYLATION; RESTORATION; SYNTHESIS (CHEMICAL);

PROTEINS;

ACETYL COENZYME A; ACETYLCARNITINE; ACETYLCYSTEINE; AMINO ACID; CARBOHYDRATE; CYTOCHROME B; FATTY ACID; KETONE BODY; MITOCHONDRIAL PROTEIN; STEROL; UBIQUINOL CYTOCHROME C REDUCTASE;

ACETYLATION; AGED; CITRIC ACID CYCLE; DIET SUPPLEMENTATION; DRUG ABSORPTION; DRUG BLOOD LEVEL; DRUG DISTRIBUTION; DRUG EXCRETION; ENZYME ACTIVITY; GENE EXPRESSION; HUMAN; METABOLISM; MITOCHONDRION; NONHUMAN; OXIDATIVE PHOSPHORYLATION; PRIORITY JOURNAL; PROTEIN SYNTHESIS; REVIEW; SYNTHESIS;

ACETYLCARNITINE; AGED; ANIMALS; ANTIOXIDANTS; DIETARY SUPPLEMENTS; HUMANS; MITOCHONDRIA; MODELS, BIOLOGICAL; REJUVENATION;

EID: 71549116704     PISSN: 0169409X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.addr.2009.06.009     Document Type: Review

References (163)

1. Brown G. The Living End: The Future of Death, Aging and Immortality (2008), Palgrave Macmillan
2. Lesnefsky E.J., and Hoppel C.L. Oxidative phosphorylation and aging. Ageing Res. Rev. 5 (2006) 402-433
3. Montgomery S.A., Thal L.J., and Amrein R. Meta-analysis of double blind randomized controlled clinical trials of acetyl-L-carnitine versus placebo in the treatment of mild cognitive impairment and mild Alzheimer's disease. Int. Clin. Psychopharmacol. 18 (2003) 61-71
4. Evans J.D., Jacobs T.F., and Evans E.W. Role of acetyl-L-carnitine in the treatment of diabetic peripheral neuropathy. Ann. Pharmacother. 42 (2008) 1686-1691
5. Sima A.A. Acetyl-L-carnitine in diabetic polyneuropathy: experimental and clinical data. CNS Drugs 21 (2007) 13-23
6. Iwase M., Ouchi Y., Okada H., Yokoyama C., Nobezawa S., Yoshikawa E., Tsukada H., Takeda M., Yamashita K., Takeda M., Yamaguti K., Kuratsune H., Shimizu A., and Watanabe Y. Neural substrates of human facial expression of pleasant emotion induced by comic films: a PET Study. NeuroImage 17 (2002) 758-768
7. Minkler P.E., Stoll M.S., Ingalls S.T., Yang S., Kerner J., and Hoppel C.L. Quantification of carnitine and acylcarnitines in biological matrices by HPLC electrospray ionization-mass spectrometry. Clin. Chem. 54 (2008) 1451-1462
8. Hoppel C.L., and Genuth S.M. Urinary excretion of acetylcarnitine during human diabetic and fasting ketosis. Am. J. Physiol. 243 (1982) E168-E172
9. Terman A., and Brunk U.T. Aging as a catabolic malfunction. Int. J. Biochem. Cell Biol. 36 (2004) 2365-2375
10. Beckman K.B., and Ames B.N. The free radical theory of aging matures. Physiol. Rev. 78 (1998) 547-581
11. Cadenas E., and Davies K.J. Mitochondrial free radical generation, oxidative stress, and aging. Free Radic. Biol. Med. 29 (2000) 222-230
12. Richter C. Oxidative damage to mitochondrial DNA and its relationship to ageing. Int. J. Biochem. Cell Biol. 27 (1995) 647-653
13. Salvioli S., Bonafè M., Capri M., Monti D., and Franceschi C. Mitochondria, aging and longevity-a new perspective. FEBS Lett. 492 (2001) 9-13
14. Kwong L.K., and Sohal R.S. Age-related changes in activities of mitochondrial electron transport complexes in various tissues of the mouse. Arch. Biochem. Biophys. 373 (2000) 16-22
15. Fannin S.W., Lesnefsky E.J., Slabe T.J., Hassan M.O., and Hoppel C.L. Aging selectivity decreases oxidative capacity in rat heart interfibrillar mitochondria. Arch. Biochem. Biophys. 372 (1999) 399-407
16. Lesnefsky E.J., Gudz T.I., Moghaddas S., Migita C.T., Ikeda-Saito M., Trukaly P.J., and Hoppel C.L. Aging decreases electron transport complex III activity in heart interfibrillar mitochondria by alteration of the cytochrome c binding site. J. Mol. Cell. Cardiol. 33 (2001) 37-47
17. Lesnefsky E.J., Moghaddas S., Tandler B., Kerner J., and Hoppel C.L. Mitochondrial dysfunction in cardiac disease: Ischemia-reperfusion, aging, and heart failure. J. Mol. Cell. Cardiol. 33 (2001) 1065-1089
18. O site of complex III augments oxyradical production in rat heart interfibrillar mitochondria. Arch. Biochem. Biophys. 414 (2003) 59-66
19. Kerner J., Turkaly P.J., Minkler P.E., and Hoppel C.L. Aging skeletal muscle mitochondria in the rat: decreased uncoupling protein-3 content. Am. J. Physiol: Endocrinol. Metab. 281 (2001) E1054-E1062
20. Huang J.H., and Hood D.A. Age-associated mitochondrial dysfunction in skeletal muscle: contributing factors and suggestions for long-term interventions. IUBMB Life 61 (2009) 201-214
21. Navarro A., and Boveris A. Rat brain and liver mitochondria develop oxidative stress and lose enzymatic activities on aging. Am. J. Physiol., Regul. Integr. Comp. Physiol. 287 (2004) R1244-R1249
22. Darnold J.R., Vorbeck M.L., and Martin A.P. Effect of aging on the oxidative phosphorylation pathway. Mech. Ageing Dev. 53 (1990) 157-167
23. Genova M.L., Castelluccio C., Fato R., Parenti Castelli G., Merlo Pich M., Formiggini G., Bovina C., Marchetti M., and Lenaz G. Major changes in complex I activity in mitochondria from aged rats may not be detected by direct assay of NADH:coenzyme Q reductase. Biochem. J. 311 (1995) 105-109
24. Okatani Y., Wakatsuki A., Reiter R.J., and Miyahara Y. Hepatic mitochondrial dysfunction in senescence-accelerated mice: correction by long-term, orally administered physiological levels of melatonin. J. Pineal Res. 33 (2002) 127-133
25. Cocco T., Sgobbo P., Clemente M., Lopriore B., Grattagliano I., Di Paola M., and Villani G. Tissue-specific changes of mitochondrial functions in aged rats: effect of a long-term dietary treatment with N-acetylcysteine. Free Radic. Biol. Med. 38 (2005) 796-805
26. Navarro A., López-Cepero J.M., Bández M.J., Sánchez-Pino M.J., Gómez C., Cadenas E., and Boveris A. Hippocampal mitochondrial dysfunction in rat aging. Am. J. Physiol., Regul. Integr. Comp. Physiol. 294 (2008) R501-R509
27. Palmer J.W., Tandler B., and Hoppel C.L. Biochemical properties of subsarcolemmal and interfibrillar mitochondria isolated from rat cardiac muscle. J. Biol. Chem. 252 (1977) 8731-8739
28. Lesnefsky E.J., He D., Moghaddas S., and Hoppel C.L. Reversal of mitochondrial defects before ischemia protects the aged heart. FASEB J. 20 (2006) 1543-1545
29. Hoppel C.L., Tandler B., Parland W., Turkay J.S., and Albers L.D. Hamster cardiomyopathy. A defect in oxidative phosphorylation in the cardiac interfibrillar mitochondria. J. Biol. Chem. 257 (1982) 1540-1548
30. Hansford R.G. Lipid oxidation by heart mitochondria from young adult and senescent rats. Biochem. J. 170 (1978) 285-295
31. Paradies G., Ruggiero F.M., Dinoi P., Petrosillo G., and Quagliariello E. Decreased cytochrome oxidase activity and changes in phospholipids in heart mitochondria from hypothyroid rats. Arch. Biochem. Biophys. 307 (1993) 91-95
32. Paradies G., Ruggiero F.M., Petrosillo G., and Quagliariello E. Enhanced cytochrome oxidase activity and modification of lipids in heart mitochondria from hyperthyroid rats. Biochim. Biophys. Acta, Mol. Cell Biol. Lipids 1225 (1994) 165-170
33. Paradies G., Ruggiero F.M., Petrosillo G., and Quagliariello E. Age-dependent decline in the cytochrome c oxidase activity in rat heart mitochondria: role of cardiolipin. FEBS Lett. 406 (1997) 136-138
34. Trumpower B.L. The protonmotive Q cycle. Energy transduction by coupling of proton translocation to electron transfer by the cytochrome bc1 complex. J. Biol. Chem. 265 (1990) 11409-11412
35. Crofts A.R., Barquera B., Gennis R.B., Kuras R., Guergova-Kuras M., and Berry E.A. Mechanism of ubiquinol oxidation by the bc(1) complex: different domains of the quinol binding pocket and their role in the mechanism and binding of inhibitors. Biochemistry 38 (1999) 15807-15826
36. Crofts A.R., Guergova-Kuras M., Huang L., Kuras R., Zhang Z., and Berry E.A. Mechanism of ubiquinol oxidation by the bc(1) complex: role of the iron sulfur protein and its mobility. Biochemistry 38 (1999) 15791-15806
37. Lesnefsky E.J., Gudz T.I., Migita C.T., Ikeda-Saito M., Hassan M.O., Turkaly P.J., and Hoppel C.L. Ischemic injury to mitochondrial electron transport in the aging heart: damage to the iron-sulfur protein subunit of electron transport complex III. Arch. Biochem. Biophys. 385 (2001) 117-128
38. Chen Q., Camara A.K., Stowe D.F., Hoppel C.L., and Lesnefsky E.J. Modulation of electron transport protects cardiac mitochondria and decreases myocardial injury during ischemia and reperfusion. Am. J. Physiol., Cell. Physiol. 292 (2007) C137-C147
39. Murry C.E., Richard V.J., Reimer K.A., and Jennings R.B. Ischemic preconditioning slows energy metabolism and delays ultrastructural damage during a sustained ischemic episode. Circ. Res. 66 (1990) 913-931
40. Flameng W., Andres J., Ferdinande P., Mattheussen M., and Van Belle H. Mitochondrial function in myocardial stunning. J. Mol. Cell. Cardiol. 23 (1991) 1-11
41. Lesnefsky E.J., Tandler B., Ye J., Slabe T.J., Turkaly J., and Hoppel C.L. Myocardial ischemia decreases oxidative phosphorylation through cytochrome oxidase in subsarcolemmal mitochondria. Am. J. Physiol. 273 (1997) H1544-H1554
42. Rouslin W. Mitochondrial complexes I, II, III, IV, and V in myocardial ischemia and autolysis. Am. J. Physiol. 244 (1983) H743-H748
43. Piper H.M., Sezer O., Schleyer M., Schwartz P., Hütter J.F., and Spieckermann P.G. Development of ischemia-induced damage in defined mitochondrial subpopulations. J. Mol. Cell. Cardiol. 17 (1985) 885-896
44. Asimakis G.K., and Conti V.R. Myocardial ischemia: correlation of mitochondrial adenine nucleotide and respiratory function. J. Mol. Cell. Cardiol. 16 (1984) 439-448
45. Duan J., and Karmazyn M. Relationship between oxidative phosphorylation and adenine nucleotide translocase activity of two populations of cardiac mitochondria and mechanical recovery of ischemic hearts following reperfusion. Can. J. Physiol. Pharmacol. 67 (1989) 704-709
46. Green D.R., and Reed J.C. Mitochondria and apoptosis. Science 281 (1998) 1309-1312
47. Chen Q., Moghaddas S., Hoppel C.L., and Lesnefsky E.J. Ischemic defects in the electron transport chain increase the production of reactive oxygen species from isolated rat heart mitochondria. Am. J. Physiol., Cell. Physiol. 294 (2008) C460-C466
48. Lesnefsky E.J., Lundergan C.F., Hodgson J.M., Nair R., Reiner J.S., Greenhouse S.W., Califf R.M., and Ross A.M. Increased left ventricular dysfunction in elderly patients despite successful thrombolysis: the GUSTO-I angiographic experience. J. Am. Coll. Cardiol. 28 (1996) 331-337
49. Lucas D.T., and Szweda L.I. Cardiac reperfusion injury: aging, lipid peroxidation, and mitochondrial dysfunction. Proc. Natl. Acad. Sci. U. S. A. 95 (1998) 510-514
50. Lesnefsky E.J., Gallo D.S., Ye J., Whittingham T.S., and Lust W.D. Aging increases ischemia-reperfusion injury in the isolated, buffer-perfused heart. J. Lab. Clin. Med. 124 (1994) 843-851
51. Frolkis V.V., Frolkis R.A., Mkhitarian L.S., and Fraifeld V.E. Age-dependent effects of ischemia and reperfusion on cardiac function and Ca2+ transport in myocardium. Gerontology 37 (1991) 233-239
52. Liu L., Azhar G., Gao W., Zhang X., and Wei J.Y. Bcl-2 and Bax expression in adult rat hearts after coronary occlusion: age-associated differences. Am. J. Physiol. 275 (1998) R315-R322
53. Ataka K., Chen D., Levitsky S., Jimenez E., and Feinberg H. Effect of aging on intracellular Ca2+, pHi, and contractility during ischemia and reperfusion. Circulation 86 (1992) II371-II376
54. Chen Q., Vazquez E.J., Moghaddas S., Hoppel C.L., and Lesnefsky E.J. Production of reactive oxygen species by mitochondria: central role of complex III. J. Biol. Chem. 278 (2003) 36027-36031
55. Lesnefsky E.J., Chen Q., Moghaddas S., Hassan M.O., Tandler B., and Hoppel C.L. Blockade of electron transport during ischemia protects cardiac mitochondria. J. Biol. Chem. 279 (2004) 47961-47967
56. Chen Q., Hoppel C.L., and Lesnefsky E.J. Blockade of electron transport before cardiac ischemia with the reversible inhibitor amobarbital protects rat heart mitochondria. J. Pharmacol. Exp. Ther. 316 (2006) 200-207
57. Aldakkak M., Stowe D.F., Chen Q., Lesnefsky E.J., and Camara A.K. Inhibited mitochondrial respiration by amobarbital during cardiac ischaemia improves redox state and reduces matrix Ca2+ overload and ROS release. Cardiovasc. Res. 77 (2008) 406-415
58. Chen Q., Moghaddas S., Hoppel C.L., and Lesnefsky E.J. Reversible blockade of electron transport during ischemia protects mitochondria and decreases myocardial injury following reperfusion. J. Pharmacol. Exp. Ther. 319 (2006) 1405-1412
59. Morley J.E., Baumgartner R.N., Roubenoff R., Mayer J., and Nair K.S. Sarcopenia. J. Lab. Clin. Med. 137 (2001) 231-243
60. Lee C.M., Aspnes L.E., Chung S.S., Weindruch R., and Aiken J.M. Influences of caloric restriction on age-associated skeletal muscle fiber characteristics and mitochondrial changes in rats and mice. Ann. N.Y. Acad. Sci. 854 (1998) 182-191
61. Lanza I.R., Befroy D.E., and Kent-Braun J.A. Age-related changes in ATP-producing pathways in human skeletal muscle in vivo. J. Appl. Physiol. 99 (2005) 1736-1744
62. Ventura-Clapier R., Garnier A., and Veksler V. Transcriptional control of mitochondrial biogenesis: the central role of PGC-1alpha. Cardiovasc. Res. 79 (2008) 208-217
63. Beyer R.E., Starnes J.W., Edington D.W., Lipton R.J., Compton R.T.r., and Kwasman M.A. Exercise-induced reversal of age-related declines of oxidative reactions, mitochondrial yield, and flavins in skeletal muscle of the rat. Mech. Ageing Dev. 24 (1984) 309-323
64. Rasmussen U.F., Krustrup P., Kjaer M., and Rasmussen H.N. Experimental evidence against the mitochondrial theory of aging-a study of isolated human skeletal muscle mitochondria. Exp. Gerontol. 38 (2003) 877-886
65. Rasmussen U.F., Krustrup P., Kjaer M., and Rasmussen H.N. Human skeletal muscle mitochondrial metabolism in youth and senescence: no signs of functional changes in ATP formation and mitochondrial oxidative capacity. Pflugers Arch. 446 (2003) 270-278
66. Barrientos A., Casademont J., Rötig A., Miró O., Urbano-Márquez A., Rustin P., and Cardellach F. Absence of relationship between the level of electron transport chain activities and aging in human skeletal muscle. Biochem. Biophys. Res. Commun. (1996)
67. Tonkonogi M., Fernström M., Walsh B., Ji L.L., Rooyackers O., Hammarqvist F., Wernerman J., and Sahlin K. Reduced oxidative power but unchanged antioxidative capacity in skeletal muscle from aged humans. Pflugers Arch. 446 (2003) 261-269
68. Figueiredo P.A., Powers S.K., Ferreira R.M., Appell H.J., and Duarte J.A. Aging impairs skeletal muscle mitochondrial bioenergetic function. J. Gerontol., Ser. A, Biol. Sci. Med. Sci. 64 (2009) 21-33
69. Sugiyama S., Takasawa M., Hayakawa M., and Ozawa T. Changes in skeletal muscle, heart and liver mitochondrial electron transport activities in rats and dogs of various ages. Biochem. Mol. Biol. Int. 30 (1993) 937-944
70. Choksi K.B., Nuss J.E., Deford J.H., and Papaconstantinou J. Age-related alterations in oxidatively damaged proteins of mouse skeletal muscle mitochondrial electron transport chain complexes. Free Radic. Biol. Med. 45 (2008) 826-838
71. Mansouri A., Muller F.L., Liu Y., Ng R., Faulkner J., Hamilton M., Richardson A., Huang T.T., Epstein C.J., and Van Remmen H. Alterations in mitochondrial function, hydrogen peroxide release and oxidative damage in mouse hind-limb skeletal muscle during aging. Mech. Ageing Dev. 127 (2006) 298-306
72. Navarro A., Sánchez-Pino M.J., Gómez C., Bández M.J., Cadenas E., and Boveris A. Dietary thioproline decreases spontaneous food intake and increases survival and neurological function in mice. Antioxid. Redox Signal. 9 (2007) 131-141
73. Boveris A., and Navarro A. Brain mitochondrial dysfunction in aging. IUBMB Life 60 (2008) 308-314
74. Navarro A., Gomez C., López-Cepero J.M., and Boveris A. Beneficial effects of moderate exercise on mice aging: survival, behavior, oxidative stress, and mitochondrial electron transfer. Am. J. Physiol., Regul. Integr. Comp. Physiol. 286 (2004) R505-R511
75. Ojaimi J., Masters C.L., Opeskin K., McKelvie P., and Byrne E. Mitochondrial respiratory chain activity in the human brain as a function of age. Mech. Ageing Dev. 111 (1999) 39-47
76. Itoh K., Weis S., Mehraein P., and Müller-Höcker J. Cytochrome c oxidase defects of the human substantia nigra in normal aging. Neurobiol. Aging 17 (1996) 843-848
77. Tian L., Cai Q., and Wei H. Alterations of antioxidant enzymes and oxidative damage to macromolecules in different organs of rats during aging. Free Radic. Biol. Med. 24 (1998) 1477-1484
78. Haripriya D., Devi M.A., Kokilavani V., Sangeetha P., and Panneerselvam C. Age-dependent alterations in mitochondrial enzymes in cortex, striatum and hippocampus of rat brain-potential role of L-carnitine. Biogerontology 5 (2004) 355-364
79. Vazquez E.J., and Hoppel C.L. Aging decreases the activity of complex III in rat hepatic mitochondria. FASEB J. 18 (2004)
80. Vazquez E.J., and Hoppel C.L. Aging decreases mitochondrial electron transport at complex III. FASEB J. 19 (2005)
81. Castelluccio C., Baracca A., Fato R., Pallotti F., Maranesi M., Barzanti V., Gorini A., Villa R.F., Castelli G.P., Marchetti M., and Lenaz G. Mitochondrial activities of rat heart during ageing. Mech. Ageing Dev. 76 (1994) 73-88
82. Liu J., Head E., Gharib A.M., Yuan W., Ingersoll R.T., Hagen T.M., Cotman C.W., and Ames B.N. Memory loss in old rats is associated with brain mitochondrial decay and RNA/DNA oxidation: partial reversal by feeding acetyl-L-carnitine and/or R-alpha -lipoic acid. Proc. Natl. Acad. Sci. U. S. A. 99 (2002) 2356-2361
83. Liu J., Atamna H., Kuratsune H., and Ames B.N. Delaying brain mitochondrial decay and aging with mitochondrial antioxidants and metabolites. Ann. N.Y. Acad. Sci. 959 (2002) 133-166
84. Hirai K., Aliev G., Nunomura A., Fujioka H., Russell R.L., Atwood C.S., Johnson A.B., Kress Y., Vinters H.V., Tabaton M., Shimohama S., Cash A.D., Siedlak S.L., Harris P.L., Jones P.K., Petersen R.B., Perry G., and Smith M.A. Mitochondrial abnormalities in Alzheimer's disease. J. Neurosci. 21 (2001) 3017-3023
85. Robinson N.C. Functional binding of cardiolipin to cytochrome c oxidase. J. Bioenerg. Biomembranes 25 (1993) 153-163
86. Schlame M., Rua D., and Greenberg M.L. The biosynthesis and functional role of cardiolipin. Prog. Lipid Res. 39 (2000) 257-288
87. Hoch F.L. Cardiolipins and biomembrane function. Biochim. Biophys. Acta 1113 (1992) 71-133
88. Hoch F.L. Cardiolipins and mitochondrial proton-selective leakage. J. Bioenerg. Biomembranes 30 (1998) 511-532
89. Nalecz K.A., Bolli R., Wojtczak L., and Azzi A. The monocarboxylate carrier from bovine heart mitochondria: partial purification and its substrate-transporting properties in a reconstituted system. Biochim. Biophys. Acta 851 (1986) 29-37
90. Fry M., and Green D.E. Cardiolipin requirement by cytochrome oxidase and the catalytic role of phospholipid. Biochem. Biophys. Res. Commun. 93 (1980) 1238-1246
91. Fry M., and Green D.E. Cardiolipin requirement for electron transfer in complex I and III of the mitochondrial respiratory chain. J. Biol. Chem. 256 (1981) 1874-1880
92. Paradies G., Petrosillo G., and Ruggiero F.M. Cardiolipin-dependent decrease of cytochrome c oxidase activity in heart mitochondria from hypothyroid rats. Biochim. Biophys. Acta 1319 (1997) 5-8
93. Beyer K., and Nuscher B. Specific cardiolipin binding interferes with labeling of sulfhydryl residues in the adenosine diphosphate/adenosine triphosphate carrier protein from beef heart mitochondria. Biochemistry 35 (1996) 15784-15790
94. Pfeiffer K., Gohil V., Stuart R.A., Hunte C., Brandt U., Greenberg M.L., and Schagger H. Cardiolipin stabilizes respiratory chain supercomplexes. J. Biol. Chem. 278 (2003) 52873-52880
95. Tuominen E.K., Wallace C.J., and Kinnunen P.K. Phospholipid-cytochrome c interaction: evidence for the extended lipid anchorage. J. Biol. Chem. 277 (2002) 8822-8826
96. Sedlak E., Panda M., Dale M.P., Weintraub S.T., and Robinson N.C. Photolabeling of cardiolipin binding subunits within bovine heart cytochrome c oxidase. Biochemistry 45 (2006) 746-754
97. Paradies G., Ruggiero F.M., Gadaleta M.N., and Quagliariello E. The effect of aging and acetyl-L-carnitine on the activity of the phosphate carrier and on the phospholipid composition in rat heart mitochondria. Biochim. Biophys. Acta 1103 (1992) 324-326
98. Paradies G., Ruggiero F.M., Petrosillo G., Gadaleta M.N., and Quagliariello E. Effect of aging and acetyl-L-carnitine on the activity of cytochrome oxidase and adenine nucleotide translocase in rat heart mitochondria. FEBS Lett. 350 (1994) 213-215
99. Iossa S., Mollica M.P., Lionetti L., Crescenzo R., Botta M., Barletta A., and Liverini G. Acetyl-L-carnitine supplementation differently influences nutrient partitioning, serum leptin concentration and skeletal muscle mitochondrial respiration in young and old rats. J. Nutr. 132 (2002) 636-642
100. Hagen T.M., Ingersoll R.T., Wehr C.M., Lykkesfeldt J., Vinarsky V., Bartholomew J.C., Song M.H., and Ames B.N. Acetyl-L-carnitine fed to old rats partially restores mitochondrial function and ambulatory activity. Proc. Natl. Acad. Sci. U. S. A. 95 (1998) 9562-9566
101. Moghaddas S., Stoll M.S., Minkler P.E., Salomon R.G., Hoppel C.L., and Lesnefsky E.J. Preservation of cardiolipin content during aging in rat heart interfibrillar mitochondria. J. Gerontol., Ser. A, Biol. Sci. Med. Sci. 57 (2002) B22-B28
102. Moriggi M., Cassano P., Vasso M., Capitanio D., Fania C., Musicco C., Pesce V., Gadaleta M.N., and Gelfi C. A DIGE approach for the assessment of rat soleus muscle changes during unloading: effect of acetyl-L-carnitine supplementation. Proteomics 8 (2008) 3588-3604
103. Gadaleta M.N., Petruzzella V., Renis M., Fracasso F., and Cantatore P. Reduced transcription of mitochondrial DNA in the senescent rat. Tissue dependence and effect of L-carnitine. Eur. J. Biochem. 187 (1990) 501-506
104. Gross C.J., Henderson L.M., and Savaiano D.A. Uptake of L-carnitine, D-carnitine and acetyl-L-carnitine by isolated guinea-pig enterocytes. Biochim. Biophys. Acta 886 (1986) 425-433
105. Parnetti L., Gaiti A., Mecocci P., Cadini D., and Senin U. Pharmacokinetics of IV and oral acetyl-L-carnitine in a multiple dose regimen in patients with senile dementia of Alzheimer type. Eur. J. Clin. Pharmacol. 42 (1992) 89-93
106. Marzo A., Arrigoni Martelli E., Urso R., Rocchetti M., Rizza V., and Kelly J.G. Metabolism and disposition of intravenously administered acetyl-L-carnitine in healthy volunteers. Eur. J. Clin. Pharmacol. 37 (1989) 59-63
107. Molstad P., Bohmer T., and Eiklid K. Specificity and characteristics of the carnitine transport in human heart cells (CCL 27) in culture. Biochim. Biophys. Acta 471 (1977) 296-304
108. Ohashi R., Tamai I., Yabuuchi H., Nezu J.I., Oku A., Sai Y., Shimane M., and Tsuji A. Na(+)-dependent carnitine transport by organic cation transporter (OCTN2): its pharmacological and toxicological relevance. J. Pharmacol. Exp. Ther. 291 (1999) 778-784
109. Tamai I., Ohashi R., Nezu J., Yabuuchi H., Oku A., Shimane M., Sai Y., and Tsuji A. Molecular and functional identification of sodium ion-dependent, high affinity human carnitine transporter OCTN2. J. Biol. Chem. 273 (1998) 20378-20382
110. Bremer J. Carnitine-metabolism and functions. Physiol. Rev. 63 (1983) 1420-1480
111. Ramsay R.R., and Zammit V.A. Carnitine acyltransferases and their influence on CoA pools in health and disease. Mol. Aspects Med. 25 (2004) 475-493
112. Ricciolini R., Scalibastri M., Kelleher J.K., Carminati P., Calvani M., and Arduini A. Role of acetyl-L-carnitine in rat brain lipogenesis: implications for polyunsaturated fatty acid biosynthesis. J. Neurochem. 71 (1998) 2510-2517
113. Kuratsune H., Watanabe Y., Yamaguti K., Jacobsson G., Takahashi M., Machii T., Onoe H., Onoe K., Matsumura K., Valind S., Kitani T., and Langstrom B. High uptake of [2-11C]acetyl-L-carnitine into the brain: a PET study. Biochem. Biophys. Res. Commun. 231 (1997) 488-493
114. Tucek S. Short-term control of the synthesis of acetylcholine. Prog. Biophys. Mol. Biol. 60 (1993) 59-69
115. Aureli T., Puccetti C., Di Cocco M.E., Arduini A., Ricciolini R., Scalibastri M., Manetti C., and Conti F. Entry of [(1, 2-13C2)acetyl]-L-carnitine in liver tricarboxylic acid cycle and lipogenesis: a study by 13C NMR spectroscopy in conscious, freely moving rats. Eur. J. Biochem. 263 (1999) 287-293
116. Farrell S., Vogel J., and Bieber L.L. Entry of acetyl-L-carnitine into biosynthetic pathways. Biochim. Biophys. Acta 876 (1986) 175-177
117. Lligona-Trulla L., Arduini A., Aldaghlas T.A., Calvani M., and Kelleher J.K. Acetyl-L-carnitine flux to lipids in cells estimated using isotopomer spectral analysis. J. Lipid Res. 38 (1997) 1454-1462
118. Kerner J., Minkler P.E., Lesnefsky E.J., and Hoppel C.L. Fatty acid chain-elongation in perfused rat heart: synthesis of stearoylcarnitine from perfused palmitate. FEBS Lett. 581 (2007) 4491-4494
119. Morikawa T., Yasuno R., and Wada H. Do mammalian cells synthesize lipoic acid? Identification of a mouse cDNA encoding a lipoic acid synthase located in mitochondria. FEBS Lett. 498 (2001) 16-21
120. Shen W., Liu K., Tian C., Yang L., Li X., Ren J., Packer L., Head E., Sharman E., and Liu J. Protective effects of R-alpha-lipoic acid and acetyl-L-carnitine in MIN6 and isolated rat islet cells chronically exposed to oleic acid. J. Cell. Biochem. 104 (2008) 1232-1243
121. Witkowski A., Joshi A.K., and Smith S. Coupling of the de novo fatty acid biosynthesis and lipoylation pathways in mammalian mitochondria. J. Biol. Chem. 282 (2007) 14178-14185
122. Hansford R.G., and Castro F. Age-linked changes in the activity of enzymes of the tricarboxylate cycle and lipid oxidation, and of carnitine content, in muscles of the rat. Mech. Ageing Dev. 19 (1982) 191-200
123. Maccari F., Arseni A., Chiodi P., Ramacci M.T., and Angelucci L. Levels of carnitines in brain and other tissues of rats of different ages: effect of acetyl-L-carnitine administration. Exp. Gerontol. 25 (1990) 127-134
124. Rebouche C.J. Carnitine function and requirements during the life cycle. FASEB J. 6 (1992) 3379-3386
125. Liu J., and Ames B.N. Reducing mitochondrial decay with mitochondrial nutrients to delay and treat cognitive dysfunction, Alzheimer's disease, and Parkinson's disease. Nutr. Neurosci. 8 (2005) 67-89
126. Minkler P.E., Anderson V.E., Maiti N.C., Kerner J., and Hoppel C.L. Isolation and identification of two isomeric forms of malonyl-coenzyme A in commercial malonyl-coenzyme A. Anal. Biochem. 328 (2004) 203-209
127. Makar T.K., Cooper A.J., Tofel-Grehl B., Thaler H.T., and Blass J.P. Carnitine, carnitine acetyltransferase, and glutathione in Alzheimer brain. Neurochem. Res. 20 (1995) 705-711
128. Liu J., Killilea D.W., and Ames B.N. Age-associated mitochondrial oxidative decay: improvement of carnitine acetyltransferase substrate-binding affinity and activity in brain by feeding old rats acetyl-L- carnitine and/or R-alpha -lipoic acid. Proc. Natl. Acad. Sci. U. S. A. 99 (2002) 1876-1881
129. Schinetti M.L., Rossini D., Greco R., and Bertelli A. Protective action of acetylcarnitine on NADPH-induced lipid peroxidation of cardiac microsomes. Drugs Exp. Clin. Res. 13 (1987) 509-515
130. Reznick A.Z., Kagan V.E., Ramsey R., Tsuchiya M., Khwaja S., Serbinova E.A., and Packer L. Antiradical effects in L-propionyl carnitine protection of the heart against ischemia-reperfusion injury: the possible role of iron chelation. Arch. Biochem. Biophys. 296 (1992) 394-401
131. Calabrese V., Ravagna A., Colombrita C., Scapagnini G., Guagliano E., Calvani M., Butterfield D.A., and Giuffrida Stella A.M. Acetylcarnitine induces heme oxygenase in rat astrocytes and protects against oxidative stress: involvement of the transcription factor Nrf2. J. Neurosci. Res. 79 (2005) 509-521
132. Virmani A., Gaetani F., Binienda Z., Xu A., Duhart H., and Ali S.F. Role of mitochondrial dysfunction in neurotoxicity of MPP+: partial protection of PC12 cells by acetyl-L-carnitine. Ann. N.Y. Acad. Sci. 1025 (2004) 267-273
133. Snyder J.W., Kyle M.E., and Ferraro T.N. L-carnitine delays the killing of cultured hepatocytes by 1-methyl-4-phenyl-1, 2, 3, 6-tetrahydropyridine. Arch. Biochem. Biophys. 276 (1990) 132-138
134. Petrosillo G., Casanova G., Matera M., Ruggiero F.M., and Paradies G. Interaction of peroxidized cardiolipin with rat-heart mitochondrial membranes: induction of permeability transition and cytochrome c release. FEBS Lett. 580 (2006) 6311-6316
135. Steffen V., Santiago M., de la Cruz C.P., Revilla E., Machado A., and Cano J. Effect of intraventricular injection of 1-methyl-4-phenylpyridinium: protection by acetyl-L-carnitine. Hum. Exp. Toxicol. 14 (1995) 865-871
136. Panahian N., Yoshiura M., and Maines M.D. Overexpression of heme oxygenase-1 is neuroprotective in a model of permanent middle cerebral artery occlusion in transgenic mice. J. Neurochem. 72 (1999) 1187-1203
137. Schipper H.M. Heme oxygenase-1: role in brain aging and neurodegeneration. Exp. Gerontol. 35 (2000) 821-830
138. Takeda A., Perry G., Abraham N.G., Dwyer B.E., Kutty R.K., Laitinen J.T., Petersen R.B., and Smith M.A. Overexpression of heme oxygenase in neuronal cells, the possible interaction with Tau. J. Biol. Chem. 275 (2000) 5395-5399
139. Di Cesare Mannelli L., Ghelardini C., Calvani M., Nicolai R., Mosconi L., Vivoli E., Pacini A., and Bartolini A. Protective effect of acetyl-L-carnitine on the apoptotic pathway of peripheral neuropathy. Eur. J. NeuroSci. 26 (2007) 820-827
140. Lee T.I., Causton H.C., Holstege F.C., Shen W.C., Hannett N., Jennings E.G., Winston F., Green M.R., and Young R.A. Redundant roles for the TFIID and SAGA complexes in global transcription. Nature 405 (2000) 701-704
141. Kim D.H., Kim M., and Kwon H.J. Histone deacetylase in carcinogenesis and its inhibitors as anti-cancer agents. J. Biochem. Mol. Biol. 36 (2003) 110-119
142. Takahashi H., McCaffery J.M., Irizarry R.A., and Boeke J.D. Nucleocytosolic acetyl-coenzyme a synthetase is required for histone acetylation and global transcription. Mol. Cell 23 (2006) 207-217
143. Alonso-Montes C., Castro M.G., Reguero J.R., Perrot A., Ozcelik C., Geier C., Posch M.G., Moris C., Alvarez V., Ruiz-Ortega M., and Coto E. Mitochondrial transcription factors TFA, TFB1 and TFB2: a search for DNA variants/haplotypes and the risk of cardiac hypertrophy. Dis. Markers 25 (2008) 131-139
144. Kim S.C., Sprung R., Chen Y., Xu Y., Ball H., Pei J., Cheng T., Kho Y., Xiao H., Xiao L., Grishin N.V., White M., Yang X.J., and Zhao Y. Substrate and functional diversity of lysine acetylation revealed by a proteomics survey. Mol. Cell 23 (2006) 607-618
145. Dinardo M.M., Musicco C., Fracasso F., Milella F., Gadaleta M.N., Gadaleta G., and Cantatore P. Acetylation and level of mitochondrial transcription factor A in several organs of young and old rats. Biochem. Biophys. Res. Commun. 301 (2003) 187-191
146. Lombard D.B., Alt F.W., Cheng H.L., Bunkenborg J., Streeper R.S., Mostoslavsky R., Kim J., Yancopoulos G., Valenzuela D., Murphy A., Yang Y., Chen Y., Hirschey M.D., Bronson R.T., Haigis M., Guarente L.P., Farese Jr. R.V., Weissman S., Verdin E., and Schwer B. Mammalian Sir2 homolog SIRT3 regulates global mitochondrial lysine acetylation. Mol. Cell. Biol. 27 (2007) 8807-8814
147. Haigis M.C., Mostoslavsky R., Haigis K.M., Fahie K., Christodoulou D.C., Murphy A.J., Valenzuela D.M., Yancopoulos G.D., Karow M., Blander G., Wolberger C., Prolla T.A., Weindruch R., Alt F.W., and Guarente L. SIRT4 inhibits glutamate dehydrogenase and opposes the effects of calorie restriction in pancreatic beta cells. Cell 126 (2006) 941-954
148. Michishita E., McCord R.A., Berber E., Kioi M., Padilla-Nash H., Damian M., Cheung P., Kusumoto R., Kawahara T.L., Barrett J.C., Chang H.Y., Bohr V.A., Ried T., Gozani O., and Chua K.F. SIRT6 is a histone H3 lysine 9 deacetylase that modulates telomeric chromatin. Nature 452 (2008) 492-496
149. Distler A.M., Kerner J., and Hoppel C.L. Post-translational modifications of rat liver mitochondrial outer membrane proteins identified by mass spectrometry. Biochim. Biophys. Acta 1774 (2007) 628-636
150. Schwer B., Bunkenborg J., Verdin R.O., Andersen J.S., and Verdin E. Reversible lysine acetylation controls the activity of the mitochondrial enzyme acetyl-CoA synthetase 2. Proc. Natl. Acad. Sci. U. S. A. 103 (2006) 10224-10229
151. Ahn B.H., Kim H.S., Song S., Lee I.H., Liu J., Vassilopoulos A., Deng C.X., and Finkel T. A role for the mitochondrial deacetylase Sirt3 in regulating energy homeostasis. Proc. Natl. Acad. Sci. U. S. A. 105 (2008) 14447-14452
152. Edwards Y.H., Chase J.F., Edwards M.R., and Tubbs P.K. Carnitine acetyltransferase: the question of multiple forms. Eur. J. Biochem. 46 (1974) 209-215
153. Cassano P., Sciancalepore A.G., Pesce V., Fluck M., Hoppeler H., Calvani M., Mosconi L., Cantatore P., and Gadaleta M.N. Acetyl-L-carnitine feeding to unloaded rats triggers in soleus muscle the coordinated expression of genes involved in mitochondrial biogenesis. Biochim. Biophys. Acta 1757 (2006) 1421-1428
154. Piantadosi C.A., Carraway M.S., Babiker A., and Suliman H.B. Heme oxygenase-1 regulates cardiac mitochondrial biogenesis via Nrf2-mediated transcriptional control of nuclear respiratory factor-1. Circ. Res. 103 (2008) 1232-1240
155. Zhang J., and Piantadosi C.A. Mitochondrial oxidative stress after carbon monoxide hypoxia in the rat brain. J. Clin. Invest. 90 (1992) 1193-1199
156. Suliman H.B., Carraway M.S., Tatro L.G., and Piantadosi C.A. A new activating role for CO in cardiac mitochondrial biogenesis. J. Cell. Sci. 120 (2007) 299-308
157. Salazar M., Rojo A.I., Velasco D., de Sagarra R.M., and Cuadrado A. Glycogen synthase kinase-3beta inhibits the xenobiotic and antioxidant cell response by direct phosphorylation and nuclear exclusion of the transcription factor Nrf2. J. Biol. Chem. 281 (2006) 14841-14851
158. Pesce V., Fracasso F., Musicco C., Lezza A.M., Cantatore P., and Gadaleta M.N. Acetyl-L-carnitine dietary supplementation to old rats increases mitochondrial transcription factor A content in rat hindlimb skeletal muscles. Ann. N.Y. Acad. Sci. 1019 (2004) 430-433
159. Paradies G., Ruggiero F.M., Petrosillo G., and Quagliariello E. Age-dependent decrease in the cytochrome c oxidase activity and changes in phospholipids in rat heart mitochondria. Arch. Gerontol. Geriatr. 16 (1993) 263-272
160. Vik S.B., and Capaldi R.A. Lipid requirements for cytochrome c oxidase activity. Biochemistry 16 (1977) 5755-5759
161. Iossa S., Mollica M.P., Lionetti L., Crescenzo R., Botta M., and Liverini G. Skeletal muscle oxidative capacity in rats fed high-fat diet. Int. J. Obes. 26 (2002) 65-72
162. Gadaleta M.N., Petruzzella V., Daddabbo L., Olivieri C., Fracasso F., Loguercio Polosa P., and Cantatore P. Mitochondrial DNA transcription and translation in aged rat. Effect of acetyl-L-carnitine. Ann. N.Y. Acad. Sci. 717 (1994) 150-160
163. Virmani A., Gaetani F., Binienda Z., Xu A., Duhart H., and Ali S.F. Role of mitochondrial dysfunction in neurotoxicity of MPP+: partial protection of PC12 cells by acetyl-L-carnitine. Ann. N.Y. Acad. Sci. 1025 (2004) 267-273